vTv Therapeutics Inc (VTVT)
25.11
-0.39
(-1.53%)
USD |
NASDAQ |
Apr 25, 12:44
vTv Therapeutics Free Cash Flow (Quarterly): -2.914M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -2.914M |
September 30, 2023 | -4.834M |
June 30, 2023 | -6.167M |
March 31, 2023 | -5.166M |
December 31, 2022 | -6.88M |
September 30, 2022 | -8.827M |
June 30, 2022 | 0.685M |
March 31, 2022 | -1.021M |
December 31, 2021 | -6.417M |
September 30, 2021 | -3.594M |
June 30, 2021 | -3.998M |
March 31, 2021 | -5.299M |
December 31, 2020 | -2.212M |
September 30, 2020 | -5.434M |
June 30, 2020 | -4.794M |
March 31, 2020 | -5.56M |
December 31, 2019 | -5.876M |
September 30, 2019 | -6.195M |
June 30, 2019 | -5.497M |
March 31, 2019 | -5.45M |
Date | Value |
---|---|
December 31, 2018 | -5.869M |
September 30, 2018 | -6.265M |
June 30, 2018 | -9.33M |
March 31, 2018 | -5.397M |
December 31, 2017 | -6.349M |
September 30, 2017 | -11.78M |
June 30, 2017 | -12.64M |
March 31, 2017 | -13.86M |
December 31, 2016 | -11.43M |
September 30, 2016 | -12.73M |
June 30, 2016 | -11.64M |
March 31, 2016 | -12.50M |
December 31, 2015 | -9.032M |
September 30, 2015 | -9.831M |
June 30, 2015 | -8.817M |
March 31, 2015 | -9.37M |
December 31, 2014 | -6.977M |
September 30, 2014 | -5.567M |
June 30, 2014 | -7.255M |
March 31, 2014 | -11.01M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.827M
Minimum
Sep 2022
0.685M
Maximum
Jun 2022
-4.737M
Average
-5.299M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
Altimmune Inc | -16.53M |
Palatin Technologies Inc | -10.51M |
Oragenics Inc | -1.102M |
Viking Therapeutics Inc | -17.64M |
G1 Therapeutics Inc | -12.79M |